• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ检测在结核性心包积液中的诊断价值:对一组伊朗患者的研究

Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients.

作者信息

Emadi Koochak Hamid, Davoudi Setareh, Salehi Omran Abbas, Mohsenipour Reyhaneh, Hajifathalian Keveh, Saeidi Behtash, Amirzargar Ali Akbar, Sotoudeh Maryam, Seifirad Soroush

机构信息

Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Acta Med Iran. 2013 Aug 7;51(7):449-53.

PMID:23945888
Abstract

Tuberculosis pericarditis as a potentially fatal complication of tuberculosis requires effective diagnosis and treatment. We evaluated the efficacy of interferon-gamma (IFN-gamma) and adenosine deaminase (ADA) for diagnosing tuberculosis pericarditis in a cohort of Iranian patients presenting with pericarditis. We enrolled 38 patients with presentation of pericarditis. All patients underwent diagnostic and therapeutic pericardiostomy with drainage and biopsy. Adenosine deaminase and interferon-gamma levels were determined in pericardial fluid samples of all patients. Pericardial tissue samples were submitted for histopathologic and microbiologic studies. Polymerase chain reaction (PCR) was performed on all pericardial fluid samples to detect Mycobacterium tuberculosis. From 38 patients with pericarditis, 7 cases were diagnosed as having tuberculosis pericarditis (18.4%). Mean concentration of interferon-gamma in tuberculosis group was significantly higher compared to non-tuberculosis group (69257 pg/l [range: 26600-148000] vs. 329 pg/l [range: 0-2200], P<0.000). Receiver operating characteristic (ROC) curve showed a value of 14400 pg/l as the cutoff point with a sensitivity of 100% and specificity of 100% for diagnosing tuberculosis pericardial effusion. Adenosine deaminase was not found to be significantly higher in tuberculosis group in comparison with non-tuberculosis causes of pericardial effusion (35.7 [range: 9-69] vs. 36.03 [range: 8-420], P=0.28). In this study interferon-gamma showed to be a valuable diagnostic test for detection of tuberculosis pericarditis among a cohort of Iranian patients. We suggest using interferon-gamma to diagnose tuberculosis pericarditis to make diagnose in case of suspicion. While in this study, adenosine deaminase measurement did not prove to have the characteristics of an accurate diagnostic test for tuberculosis pericarditis.

摘要

结核性心包炎作为结核病的一种潜在致命并发症,需要有效的诊断和治疗。我们评估了干扰素-γ(IFN-γ)和腺苷脱氨酶(ADA)在一组患有心包炎的伊朗患者中诊断结核性心包炎的疗效。我们纳入了38例有心包炎表现的患者。所有患者均接受了诊断性和治疗性心包造口引流及活检。测定了所有患者心包液样本中的腺苷脱氨酶和干扰素-γ水平。心包组织样本被送去进行组织病理学和微生物学研究。对所有心包液样本进行聚合酶链反应(PCR)以检测结核分枝杆菌。在38例心包炎患者中,7例被诊断为结核性心包炎(18.4%)。结核组干扰素-γ的平均浓度显著高于非结核组(69257 pg/l[范围:26600 - 148000]vs.329 pg/l[范围:0 - 2200],P<0.000)。受试者工作特征(ROC)曲线显示,以14400 pg/l作为诊断结核性心包积液的截断点,敏感性为100%,特异性为100%。与非结核性心包积液病因相比,结核组的腺苷脱氨酶未发现显著升高(35.7[范围:9 - 69]vs.36.03[范围:8 - 420],P = 0.28)。在本研究中,干扰素-γ被证明是在一组伊朗患者中检测结核性心包炎的有价值的诊断试验。我们建议使用干扰素-γ来诊断结核性心包炎,以便在怀疑时进行诊断。而在本研究中,腺苷脱氨酶测量并未证明具有作为结核性心包炎准确诊断试验的特征。

相似文献

1
Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients.干扰素-γ检测在结核性心包积液中的诊断价值:对一组伊朗患者的研究
Acta Med Iran. 2013 Aug 7;51(7):449-53.
2
The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis.使用腺苷脱氨酶和γ-干扰素作为结核性心包炎的诊断工具。
Chest. 2002 Sep;122(3):900-5. doi: 10.1378/chest.122.3.900.
3
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.在高负担环境下,与腺苷脱氨酶和未刺激的干扰素-γ相比,定量聚合酶链反应(Xpert MTB/RIF)对结核性心包炎的诊断准确性:一项前瞻性研究。
BMC Med. 2014 Jun 18;12:101. doi: 10.1186/1741-7015-12-101.
4
Diagnosing tuberculous pericarditis.诊断结核性心包炎。
QJM. 2006 Dec;99(12):827-39. doi: 10.1093/qjmed/hcl123.
5
Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis.腺苷脱氨酶和癌胚抗原在心包积液诊断中的应用,尤其在疑似结核性心包炎的诊断中。
Circulation. 1994 Jun;89(6):2728-35. doi: 10.1161/01.cir.89.6.2728.
6
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.胸腔积液腺苷脱氨酶和干扰素γ作为结核性胸膜炎的诊断工具。
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:349-60.
7
[The value of measuring adenosine deaminase activity in pericardial effusion fluid for diagnosing the etiology of pericardial effusion].[检测心包积液中腺苷脱氨酶活性对诊断心包积液病因的价值]
Pneumonol Alergol Pol. 1996;64 Suppl 2:174-9.
8
Clinical diagnostic utility of adenosine deaminase, interferon-γ, interferon-γ-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions.腺苷脱氨酶、γ-干扰素、γ-干扰素诱导蛋白 10kDa 和二肽基肽酶 4 水平在结核性胸腔积液中的临床诊断价值。
Heart Lung. 2012 Jan-Feb;41(1):70-5. doi: 10.1016/j.hrtlng.2011.04.049. Epub 2011 Sep 13.
9
Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis.
Cardiology. 2000;94(2):81-5. doi: 10.1159/000047296.
10
Detection of drug-resistant Mycobacterium tuberculosis in pericardial fluid culture and its correlation with cartridge based nucleic acid amplification test and adenosine deaminase activity.检测心包液培养中的耐药结核分枝杆菌及其与基于试剂盒的核酸扩增试验和腺苷脱氨酶活性的相关性。
Indian J Tuberc. 2024;71 Suppl 1:S59-S66. doi: 10.1016/j.ijtb.2023.09.014. Epub 2023 Sep 29.

引用本文的文献

1
Serosal membrane tuberculosis in Iran: A comprehensive review of evidences.伊朗的浆膜结核:证据综述
J Clin Tuberc Other Mycobact Dis. 2023 Feb 23;31:100354. doi: 10.1016/j.jctube.2023.100354. eCollection 2023 May.
2
Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis.干扰素-γ在结核性心包炎心包积液诊断中的准确性:一项荟萃分析。
J Thorac Dis. 2018 Feb;10(2):854-860. doi: 10.21037/jtd.2017.12.107.